Opinion: Free the pill — and make it free
This month, HRA Pharma announced it had submitted the first-ever application to the Food and Drug Administration to turn its birth control pill, Opill, from prescription to over-the-counter (OTC) status. This would allow people to purchase this birth control brand without a doctor’s visit and prescription, much as they might buy medicine-cabinet essentials like ibuprofen and acetaminophen.
This approach makes sense, because oral contraceptives are as safe as these and other OTC drugs, and the potential for misuse or abuse is low.
Read Original Article: Opinion: Free the pill — and make it free »
